Form 8-K · Current report
Xcel Energy 8-K, filed Nov 3, 2026
- Filed
- CIK
- 0000072903
- Accession no.
- 0001193125-26-444394
Summary
Xcel Energy priced an upsized private offering of $2.2 billion aggregate principal amount of 2.625% convertible senior notes due 2027, up from a previously announced $2.0 billion, with an option for initial purchasers to buy up to an additional $300 million. Xcel Energy expects net proceeds of about $2.1785 billion and intends to use them to repay short-term borrowings, including commercial paper and borrowings under a 364-day delayed draw term loan, and for general corporate purposes.
Key points
- The convertible notes will be senior unsecured obligations, bear interest at 2.625% per year payable semiannually, and mature on December 15, 2027.
- The initial conversion price is approximately $87.26 per share, representing a 10.0% premium over Xcel Energy's last reported sale price on November 2, 2026.
- The offering is being made to qualified institutional buyers under Rule 144A and is expected to close on November 5, 2026, subject to customary closing conditions.
- Xcel Energy may not redeem the notes before maturity, no sinking fund is provided, and holders may require repurchase at 100% of principal plus accrued interest upon a fundamental change.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On November 2, 2026, Xcel Energy Inc., a Minnesota corporation (“Xcel Energy”), issued a press release announcing the pricing of an offering of $2,200,000,000 in aggregate principal amount of 2.625% Convertible Senior Notes due 2027 (the “convertible notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.